Clinicopathological correlations in behavioural variant frontotemporal dementia
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural variant frontotemporal dementia (bvFTD) poses a daunting challenge for clinicians but will be critical for the success of disease-modifying therapies. We sought to improve pathological prediction by exploring clinicopathological correlations in a large bvFTD cohort. Among 438 patients in whom bvFTD was either the top or an alternative possible clinical diagnosis, 117 had available autopsy data, including 98 with a primary pathological diagnosis of frontotemporal lobar degeneration (FTLD), 15 with Alzheimer's disease, and four with amyotrophic lateral sclerosis who lacked neurodegenerative disease-related pathology outside of the motor system. Patients with FTLD were distributed between FTLD-tau (34 patients: 10 corticobasal degeneration, nine progressive supranuclear palsy, eight Pick's disease, three frontotemporal dementia with parkinsonism associated with chromosome 17, three unclassifiable tauopathy, and one argyrophilic grain disease); FTLD-TDP (55 patients: nine type A including one with motor neuron disease, 27 type B including 21 with motor neuron disease, eight type C with right temporal lobe presentations, and 11 unclassifiable including eight with motor neuron disease), FTLD-FUS (eight patients), and one patient with FTLD-ubiquitin proteasome system positive inclusions (FTLD-UPS) that stained negatively for tau, TDP-43, and FUS. Alzheimer's disease was uncommon (6%) among patients whose only top diagnosis during follow-up was bvFTD. Seventy-nine per cent of FTLD-tau, 86% of FTLD-TDP, and 88% of FTLD-FUS met at least 'possible' bvFTD diagnostic criteria at first presentation. The frequency of the six core bvFTD diagnostic features was similar in FTLD-tau and FTLD-TDP, suggesting that these features alone cannot be used to separate patients by major molecular class. Voxel-based morphometry revealed that nearly all pathological subgroups and even individual patients share atrophy in anterior cingulate, frontoinsula, striatum, and amygdala, indicating that degeneration of these regions is intimately linked to the behavioural syndrome produced by these diverse aetiologies. In addition to these unifying features, symptom profiles also differed among pathological subtypes, suggesting distinct anatomical vulnerabilities and informing a clinician's prediction of pathological diagnosis. Data-driven classification into one of the 10 most common pathological diagnoses was most accurate (up to 60.2%) when using a combination of known predictive factors (genetic mutations, motor features, or striking atrophy patterns) and the results of a discriminant function analysis that incorporated clinical, neuroimaging, and neuropsychological data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because isolated rATL atrophy is highly predictive of TDP-C pathology, recent studies have highlighted the importance of characterizing and isolating this syndrome from other FTD syndromes.6”
From Automated Speech Analysis to Differentiate Frontal and Right Anterior Temporal Lobe Atrophy in Frontotemporal Dementia (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatively, lesions of the Alzheimer type are frequently observed as copathology in post-mortem examination of people who had other neurodegenerative diseases.40,41,94,96”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredIn the citing paper
“This biomarker positivity is particularly ambiguous in the case of behavioural or dysexecutive variants, corticobasal syndrome, and semantic or non-fluent variants of primary progressive aphasia, in which the presence of positive Alzheimer’s disease biomarkers can be considered either as Alzheimer’s disease copathology or atypical forms of Alzheimer’s disease94,96,98,99 (appendix p 2).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 3×
“This determination was made by the reviewing clinician as has been done in prior papers establishing the sensitivity and interrater reliability of these criteria (Rascovsky et al., 2011; Lamarre et al., 2013).”
BackgroundMethodSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · cited 1×
“Patients were classified into FTLD major molecular classes (tau, TDP-43, or FUS) and subtypes (Mackenzie et al., 2010, 2011), Alzheimer’s disease (Hyman and Trojanowski, 1997; Hyman et al., 2012), or amyotrophic lateral sclerosis (ALS).”
BackgroundSelf-citationAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Self-citation
Cited by
Items 301–325 of 325
Phänomenologische und bildgebende Charakterisierung von FTD-Spektrum-Erkrankungen
Schönecker, S. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.34842
Giannini, L. A. A., Peterson, C. S., Ohm, D. T., Xie, S. X., McMillan, C. T., Raskovsky, K., Massimo, L. M., Suh, E. R., Deerlin, V. M. V., Wolk, D. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14100292
Self-citationJohnson, K. (2021) · The Sydney eScholarship Repository (The University of Sydney)
Early regional hypometabolism in presymptomatic MAPT carriers : a GENFI sub-study
St-Onge, F. (2019) · Corpus Université Laval (Université Laval)
Aronsson, F. S., Öijerstedt, L., Jelić, V., Östling, R., Östberg, P., & Graff, C. (2026) · International Journal of Speech-Language Pathology · doi:10.1080/17549507.2025.2602580
Morphometric features enhance phenotype discrimination in frontotemporal lobar degeneration
Stocks, J. K., Heywood, A. A., Popuri, K., Beg, M. F., Rosen, H. J., & Wang, L. (2026) · Brain Communications · doi:10.1093/braincomms/fcag012
“69,70 However, hemispheric discrepancies have been hypothesized to be the result of heterogeneity in underlying neuropathology, as atrophy of the right orbitofrontal cortex was shown to be more common in bvFTD due to FTLD-tau and atrophy of the left ventrolateral temporal lobes was observed in…”
Self-citationAccuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases
Vöglein, J., Arzberger, T., Ebner, I., Herms, J. W., Roeber, S., Ruf, V., Danek, A., Giese, A., Höglinger, G. U., & Levin, J. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13680-w
“These discrepancies are also true for frontotemporal lobar degeneration (FTLD) [5], multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and in particular corticobasal degeneration (CBD) [6, 7].”
SUBCORTICAL CONTRIBUTION TO SALIENCE NETWORK FUNCTION ACROSS NEURODEGENERATIVE DISEASES
Davenport, C. (2024) · TSpace (University of Toronto)
Urso, D., Giannoni‐Luza, S., Ionta, S., Mondello, S., & Logroscino, G. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70266
“16 Furthermore, while the genetics of bvFTD are expanding—with more mutations accounting for previously unexplained heritability—clinical criteria remain the cornerstone for diagnosis.”
Étude de la physiopathologie des tauopathies et modélisation chez le primate non-humain
Darricau, M. (2023) · theses.fr (ABES) · doi:10.70675/c2288979z9f7ez4b9cza735za409870e0614
Dong, J. (2025) · International Journal of Advances in Signal and Image Sciences · doi:10.29284/bsf3af03
Kikuchi, R., Ishihara, K., Shiota, J.-I., Kawamura, M., Yoshida, M., & Iwasaki, Y. (2026) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-002218
Dementias and Mild Cognitive Impairment in Adults
Boscarino, J. J., Maietta, J. E., Schoenberg, M. R., & Duff, K. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-07777-6_15
Alzheimer’s disease subtyping approaches and the role of co-pathologies
Gawor, K., Statz, K., Schaeverbeke, J. M., & Thal, D. R. (2026) · Brain · doi:10.1093/brain/awag157
Breevoort, A., Ivanov, D., Horan-Portelance, L., Nana, A. L., Vatsavayai, S. C., Tudoras, À., Wallace, J. L., Ding, J. W., Pereira, F. L., Fernhoff, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.13.738307
Self-citationTrudel, L., Therriault, J., Macedo, A. C., Rahmouni, N., Soucy, J., Gauthier, S. G., Vitali, P., Guiot, M.-C., Hazrati, L., & Rosa‐Neto, P. (2026) · Brain Communications · doi:10.1093/braincomms/fcag304
“At one end of this range, corticobasal syndrome (CBS) and behavioural variant frontotemporal dementia are only rarely associated with underlying ADNC 5-9 and are more commonly driven by non-AD pathologies.”
Czech, J., Weyland, C. S., Neumann, M., Drzezga, A. E., & Schulz, J. B. (2026) · Springer eBooks · doi:10.1007/978-3-032-13040-2_6
Oh, H. S., Downer, J. D., Dietz, C. D., Yballa, C., Marcora, E. M., Lario‐Lago, A., Heuer, H. W., Forsberg, L. K., Hsiao‐Nakamoto, J., Chiu, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.22.746470
“Patients with the same pathology can manifest disparate syndromes, and, conversely, patients with the same syndrome can harbor different pathologies 7 .”
Self-citationDistinct and shared multimodal neuroimaging patterns in clinical frontotemporal dementia syndromes
Sintini, I., Singh, N. A., Ali, F., Duffy, J. R., Clark, H. M., Utianski, R. L., Meade, G. F., Machulda, M. M., Satoh, R., Dickson, D. W., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag341
“2 18-21 Hence, neuroimaging may help close the gap between the clinic and neuropathology, being a powerful tool for discriminating in vivo between FTD syndromes 22-25 and for ruling out non-FTLD cases.”
Li, Y., Pu, K., Li, D., Zhao, Y., Cai, Q., Zhou, X., Li, S., Chen, Y., Zhou, Z., & Liu, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103376
Vilella, D., Vitulli, A., Rollo, E., Logroscino, G., & Urso, D. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01523-0
“…insular regions further support reward evaluation, conflict monitoring, interoception, salience attribution, and behavioural inhibition; degeneration in these regions may therefore contribute to disinhibition, irritability, compulsivity, abnormal eating, and reduced social sensitivity [20, 31, 32].”
Heikkinen, S. (2025) · UEF eRepo (University of Eastern Finland)
Neurotransmitter-defined cerebral vulnerability patterns in frontotemporal lobar degeneration (FTLD)
Tahedl, M., Toomey, A., Mandal, N., Mangan, S., Siah, W. F., Tan, E. L., Hardiman, O. M., Kleinerová, J., McKenna, M. C., Hutchinson, S., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14216-y
“ALS-FTD is primarily associated with pTDP-43 [27], svPPA stems from pathological TDP-43-C aggregates [28], nfvPPA is typically linked to 4R tau, [29] and molecular findings in bvFTD are heterogeneous [30].”
Metadata
- Authors
- Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., Gorno-Tempini, M. L., Boxer, A. L., De May, M., Rankin, K. P., Sturm, V. E., Lee, S. E., Matthews, B. R., Kao, A. W., Vossel, K. A., Tartaglia, M. C., Miller, Z. A., Seo, S. W., Sidhu, M., Gaus, S. E., Nana, A. L., Vargas, J. N. S., Hwang, J.-H. L., Ossenkoppele, R., Brown, A. B., Huang, E. J., Coppola, G., Rosen, H. J., Geschwind, D., Trojanowski, J. Q., Grinberg, L. T., Kramer, J. H., Miller, B. L., & Seeley, W. W.
- Affiliations
- University of California, San Francisco (US)
- Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA
- University of Minnesota (US)
- University of California, Los Angeles (US)
- University of Pennsylvania (US)
- Corresponding author
- Perry, David C
- ORCID
- Perry, David C
- Brown, Jesse A
- Possin, Katherine L
- Kornak, John
- Sias, Ana C
- Rabinovici, Gil D
- Boxer, Adam L
- Rankin, Katherine P
- Sturm, Virginia E
- Lee, Suzee E
- Kao, Aimee W
- Vossel, Keith A
- Tartaglia, Maria Carmela
- Miller, Zachary A
- Seo, Sang Won
- Nana, Alissa L
- Vargas, Jose Norberto S
- Ossenkoppele, Rik
- Huang, Eric J
- Coppola, Giovanni
- Rosen, Howard J
- Geschwind, Daniel
- Trojanowski, John Q
- Grinberg, Lea T
- Kramer, Joel H
- Miller, Bruce L
- Seeley, William W
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-06
- Volume
- 140
- Issue
- 12
- Pages
- 3329-3345
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841140
- OpenAlex
- W2760832975
- Cited by
- 309
- References
- 54
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 35 · 2023: 38 · 2022: 56 · 2021: 39 · 2020: 29 · 2019: 34 · 2018: 23 · 2017: 1
- FWCI
- 19.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- PMC
- Funders
- National Institutes of Health (P01AG019724, P50AG023501, P30AG10124, P01AG17856, K23AG045289, U54NS092089, R01AG038791)
- BrightFocus Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- behavioral variant frontotemporal dementia, clinicopathological correlation, frontotemporal lobar degeneration, FTLD-tau, FTLD-TDP, corticobasal degeneration, progressive supranuclear palsy, Pick's disease, motor neuron disease, Alzheimer's disease, voxel-based morphometry, brain atrophy, behavioral syndromes, disease-modifying therapy, symptom profiles, neuropathology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Autopsy, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Organ Size, Supranuclear Palsy, Progressive, Pick Disease of the Brain, Frontotemporal Lobar Degeneration, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.